利拉利汀是由Boehringer Ingelheim开发的用于治疗2型糖尿病的二肽基肽酶-4抑制剂。

清空选项
54012-73-6 Piperidin-3-amine
BD249954012-73-695%
¥132.00250mg常备现货
334618-23-4 (R)-Piperidin-3-amine dihydrochloride
BD2500334618-23-497%
¥101.0025g常备现货
668273-75-4 (R)-tert-Butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
BD632930668273-75-497% HPLC
¥215.001g常备现货
3355-28-0 1-Bromo-2-butyne
BD573033355-28-097%
¥21.001g常备现货
666816-98-4 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
BD232385666816-98-498%
¥10.00250mg常备现货
668270-12-0 (R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
BD161416668270-12-098%
¥75.00250mg常备现货
309956-78-3 (R)-tert-Butyl piperidin-3-ylcarbamate
BD0330309956-78-397%
¥137.0025g常备现货
853029-57-9 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
BD233973853029-57-999%
¥43.001g常备现货
109113-72-6 2-(Chloromethyl)-4-methylquinazoline
BD168632109113-72-698%
¥29.001g常备现货
93703-24-3 8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione
BD16866693703-24-398%
¥151.0025g常备现货
551-93-9 1-(2-Aminophenyl)ethanone
BD41793551-93-997%
¥752.00500g常备现货
886588-62-1 (R)-2-(Piperidin-3-yl)isoindoline-1,3-dione (2S,3S)-2,3-dihydroxysuccinate
BD247483886588-62-195+%
¥97.001g常备现货
886588-63-2 (R)-7-(But-2-ynyl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
BD00799120886588-63-298%
¥681.001g
1